Bausch + Lomb Insider Trading
TSX BLCO
9
All Trades
7
Significant
2
Notable
8
Clusters
0
Repeat
Healthcare
Sector
Medical Instruments
Industry
$8.37B
Market Cap
19.49 – 25.41
52 Week Range
2K
Avg. Volume
| Company | Insider | Title | Tr. Date | Fi. Date | Shares | Price | Value | Balance | Increase | Signal |
|---|---|---|---|---|---|---|---|---|---|---|
| Bausch + Lomb | Bailey, Ambrose | CLO | 06-Mar-26 | 10-Mar-26 | 100,940 | SI CL | ||||
| Bausch + Lomb | Saunders, Brenton | CEO | 06-Mar-26 | 10-Mar-26 | 421,221 | NT CL | ||||
| Bausch + Lomb | Eldessouky, Osama | EVP | 06-Mar-26 | 10-Mar-26 | 139,936 | NT CL | ||||
| Bausch + Lomb | Ross Sr., Thomas | Director | 03-Mar-26 | 04-Mar-26 | 17,000 | SI CL | ||||
| Bausch + Lomb | Von Eschenbach, Andrew | Director | 27-Feb-26 | 03-Mar-26 | 18,559 | SI CL | ||||
| Bausch + Lomb | Collis, Steven | Director | 23-Feb-26 | 24-Feb-26 | 15,000 | SI CL | ||||
| Bausch + Lomb | Robertson, Russel | Director | 20-Feb-26 | 24-Feb-26 | 10,208 | SI CL | ||||
| Bausch + Lomb | Ling, Karen | Director | 19-Feb-26 | 23-Feb-26 | 21,338 | SI CL | ||||
| Bausch + Lomb | Saunders, Brenton | CEO | 22-May-25 | 27-May-25 | 205,958 | SI |
Bausch + Lomb (BLCO): Insider trading △ Insider buy
Volume (thousands)
Related Companies to Explore
Company Info
Bausch + Lomb Corporation is an eye health company that operates across the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and other international markets. The company works through three business segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment offers contact lenses across various wearing modalities, including daily disposable and frequently replaced options, as well as therapeutic lenses for optical correction during healing. It also sells contact lens care products, eye vitamins, mineral supplements, and over-the-counter eye drops for conditions such as dry eye, eye allergies, conjunctivitis, and redness relief. The Pharmaceuticals segment provides both proprietary and generic pharmaceutical products targeting post-operative care, glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment supplies medical device equipment, consumables, and technologies for treating cataracts, corneal, vitreous, and retinal conditions, along with intraocular lenses, phacoemulsification equipment, and other surgical instruments. The company distributes its products through direct sales forces and independent distributors. Bausch + Lomb is headquartered in Vaughan, Canada, and operates as a subsidiary of Bausch Health Companies Inc. It is classified within the healthcare sector under medical instruments and supplies.
Don’t miss today’s trades
Full access to real-time insider buying data — $8.25/mo, billed annually. Cancel anytime.
